STRS Ohio’s 9 Meters Biopharma NMTR Stock Holding History

STRS Ohio’s Portfolio NMTR Stock Details NMTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-270	Closed	-$10K	–	2237
2019 Q1	$10K	Hold	270	–	–	﹤0.01%	2010
2018 Q4	$12K	Hold	270	–	–	﹤0.01%	2021
2018 Q3	$36K	Hold	270	–	–	﹤0.01%	1987
2018 Q2	$127K	Buy	+270	New	+$99.3K	﹤0.01%	1821

Other funds holding NMTR

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

STRS Ohio's NMTR Position: Q2 2019 in Review

STRS Ohio sold out of 9 Meters Biopharma (NMTR) in Q2 2019, closing a stake of 270 shares — an estimated $10K sold.

STRS Ohio first reported a position in NMTR in Q2 2018 and held it in 4 quarters. The position peaked at $127K in Q2 2018. 30 funds tracked by Wall St. Rank hold NMTR as of Q2 2019.

STRS Ohio reported no remaining 9 Meters Biopharma position as of Q2 2019 after selling out during the quarter.
STRS Ohio sold 270 9 Meters Biopharma shares in Q2 2019, an estimated $10K.
STRS Ohio first reported a position in 9 Meters Biopharma in Q2 2018 and held it in 4 quarters.
STRS Ohio's 9 Meters Biopharma position peaked at $127K in Q2 2018.
30 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q2 2019.

Based on STRS Ohio's 13F filing for Q2 2019, filed 25 Jul 2019.